Literature DB >> 18466832

Pathology of the ocular motor nerves III, IV, and VI.

Matthew E Adams1, Jennifer Linn, Indra Yousry.   

Abstract

The ocular motor nerves supply motor fibers to the extraocular muscles of the globe and levator muscle of the eyelid and parasympathetic pupillomotor fibers to the ciliary ganglion. Lesions are classified according to the anatomic location at which they occur: nuclear, fascicular, cisternal, cavernous, or orbital apex. The course each nerve follows influences the sites at which it is most vulnerable to damage and the pathologies to which it is exposed. Cranial nerve palsies frequently are associated with neurologic deficits that may assist in localizing the lesion anatomically. This article provides an overview of the pathology of the ocular motor nerves.

Entities:  

Mesh:

Year:  2008        PMID: 18466832     DOI: 10.1016/j.nic.2007.11.001

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  4 in total

1.  Detailed imaging of the normal anatomy and pathologic conditions of the cavernous region at 3 Tesla using a contrast-enhanced MR angiography.

Authors:  Jennifer Linn; Friederike Peters; Nina Lummel; Christoph Schankin; Walter Rachinger; Hartmut Brueckmann; Indra Yousry
Journal:  Neuroradiology       Date:  2011-01-27       Impact factor: 2.804

2.  The human trochlear and abducens nerves at different ages - a morphometric study.

Authors:  Muthu Ramkumar; Saroj Sharma; Tony G Jacob; Daya N Bhardwaj; Tapas C Nag; Tara Sankar Roy
Journal:  Aging Dis       Date:  2014-03-18       Impact factor: 6.745

3.  Isolated III cranial nerve palsy: a surprising presentation of an acute on chronic subdural haematoma.

Authors:  Muhammad Fahmi Abdul Jalil; Jin Wee Tee; Tiew Han
Journal:  BMJ Case Rep       Date:  2013-06-19

4.  Transplantation of Xenopus laevis tissues to determine the ability of motor neurons to acquire a novel target.

Authors:  Karen L Elliott; Douglas W Houston; Bernd Fritzsch
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.